Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
03/2011
03/30/2011EP2300423A1 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
03/30/2011EP1742927B1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
03/30/2011EP1441719B1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
03/30/2011EP1277738B1 Condensed heteroaryl derivatives
03/30/2011CN1898210B 2-pyridinylethylcarboxamide derivatives and their use as fungicides
03/30/2011CN101998951A Acylthiourea compound or salt thereof, and use thereof
03/30/2011CN101998852A Novel estrogen receptor ligands
03/30/2011CN101993448A Anti-mycobacteria oxazolidinones used for treating infectious disease
03/30/2011CN101993416A Quinoline compound and preparation method thereof, medicament combination containing compound and application of compound
03/30/2011CN101993410A Organic light-emitting device
03/29/2011US7915420 Aryl piperidine amides
03/29/2011US7915295 Viricides; HIV antivirals effective against problematic drug escape mutants; N-[(1S,1aR,7bR)-4,7-difluoro-1,1a,2,7b-tetrahydrocyclopropa[c]chromen-1-yl]-N'-[5-(4-(sulfonamido)phenoxy)-2-pyridinyl]urea
03/29/2011US7915260 Urotensin II receptor antagonists
03/29/2011US7915253 4-[2,6-Dimethyl-4-(4-trifluoromethoxy-phenyl)-piperazine-1-sulfonyl]-indan-2-carboxylic acid; peroxisome proliferator activated receptors modulator; antidiabetic, antiinflammatory agent; obesity, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome, ischemia-associated organ injury
03/29/2011US7915249 serotonin 5-HT2A, 5-HT2C and dopamin D2 receptors antagonist, and norepinephrine reuptake inhibitor; antidepressant, anxiolytic agent; psychosis, schizophrenia, bipolar and sexual disorders, obesity
03/29/2011US7914706 Charge transport compositions and electronic devices made with such compositions
03/29/2011CA2631880C Chromane substituted benzimidazoles and their use as acid pump inhibitors
03/29/2011CA2499536C Method of preparing amino acid taxane derivatives and polymer conjugates containing the same
03/29/2011CA2489276C Tricyclic steroid hormone nuclear receptor modulators
03/29/2011CA2469055C Aminotetralin derivatives as muscarinic receptor antagonists
03/29/2011CA2390164C Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/29/2011CA2383779C N-(indolecarbonyl)piperazine derivatives
03/29/2011CA2299139C 4-phenyl-pyridine derivatives
03/24/2011WO2011034962A2 Compounds that modulate intracellular calcium
03/24/2011WO2011034202A1 Chromene compound
03/24/2011WO2011033531A1 A reusable end-capped bipyridine compound useful for selective detection of cyanide anions and process for preparation thereof
03/24/2011WO2011033255A1 (4-phenyl-piperidin-1-yl)-[5-1h-pyrazol-4yl)-thiophen-3-yl]-methanone compounds and their use
03/24/2011WO2011033099A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
03/24/2011WO2011032277A1 Quinazolinone derivatives as viral polymerase inhibitors
03/24/2011US20110071285 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
03/24/2011US20110071195 Novel alkene oxindole derivatives
03/24/2011US20110071156 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
03/24/2011US20110071149 Selective kinase inhibitors
03/24/2011US20110071145 Raf Modulators And Methods Of Use
03/24/2011US20110071126 Inhibitors of beta-secretase
03/24/2011US20110069130 Multifunctional type ii photoinitiators and curable compositions
03/24/2011DE10106577B4 Bis(alkylthio)carbeniumsalze Bis (alkylthio) carbenium
03/24/2011CA2773832A1 Compounds useful against kinetoplastideae parasites
03/24/2011CA2772674A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
03/24/2011CA2772504A1 (4-phenyl-piperidin-1-yl)-[5-(1h-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use
03/23/2011EP2298767A1 Nitrogenated bicyclic heterocyclic compound
03/23/2011EP2298761A1 HIV inhibiting pyrimidines derivatives
03/23/2011EP2298759A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/23/2011EP2298758A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/23/2011EP2298741A1 1H-benzo[g]indole compounds and organic luminescence device using the same
03/23/2011EP2298740A1 1-H-benzo[g]indole compounds and organic lightemitting device including the same
03/23/2011EP2298738A1 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
03/23/2011EP2298737A1 Indole compounds and organic light-emitting device including the same
03/23/2011EP2297134A1 Substituted pyridin-4 -yl-methyl sulfonamides as fungicides
03/23/2011EP2297114A2 Heterocyclic compound and use thereof
03/23/2011EP2297113A1 Dual-acting antihypertensive agents
03/23/2011EP2297110A1 Indane derivatives as ampa receptor modulators
03/23/2011EP2297105A1 Substituted amides, method of making, and use as btk inhibitors
03/23/2011EP2297102A1 Heteroaromatic monoamides as orexinin receptor antagonists
03/23/2011EP2297042A2 Catalytic asymetric hydrogenation
03/23/2011EP2229358B1 Indoles and their therapeutic use
03/23/2011EP1896417B1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/23/2011CN101990538A C-met protein kinase inhibitors
03/22/2011US7910770 3-Isopropoxy-7-methoxy-N-(1H-1,2,3,4-tetrazol-5-yl)-1-benzo[b]thiophene-2-carboxamide; autoimmune diseases such as rheumatoid arthritis, immune thrombocytopenia purpura, systemic lupus erythematosus and Crohn's disease
03/22/2011US7910606 Pyrazole-derivatives as factor Xa inhibitors
03/22/2011US7910590 Cyclic amine bace-1 inhibitors having a heterocyclic substituent
03/22/2011US7908735 Method and installation means for installing an electrical machine
03/22/2011CA2622334C Thiophene derivatives for the treatment of diabetes
03/22/2011CA2480880C Inhibitors of akt activity
03/22/2011CA2478229C Pyridinoylpiperidines as 5-ht1f agonists
03/22/2011CA2432572C Oxybenzamides derivatives as factor xa inhibitors
03/17/2011WO2011031658A1 Herbicidal pyrimidone derivatives
03/17/2011WO2011030068A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease
03/17/2011WO2011029633A1 Heterocyclic mglu5 antagonists
03/17/2011WO2011006803A8 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition
03/17/2011US20110065768 Non-steroidal androgens compounds
03/17/2011US20110065724 Compounds that modulate intracellular calcium
03/17/2011US20110065713 Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors
03/17/2011US20110062426 Substituted oligo- or polythiophenes
03/17/2011US20110061723 Dye sensitised solar cell
03/17/2011CA2772697A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease
03/17/2011CA2771588A1 Herbicidal pyrimidone derivatives
03/16/2011EP2295442A2 Inhibitors of interleukin-1beta converting enzyme
03/16/2011EP2295431A2 Substantially pure eprosartan free base
03/16/2011EP2295430A2 Crystalline solid of eprosartan acetate
03/16/2011EP2295429A1 3-((hetero)aryl)-indazoles as Liver X receptor (LXR) and Th-1 inhibitors for the treatment of cardiovascular diseases
03/16/2011EP2295414A1 Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
03/16/2011EP2295413A1 Indazole compounds useful as protein kinase inhibitors
03/16/2011EP2295412A1 Indazole compounds useful as protein kinase inhibitors
03/16/2011EP2294051A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
03/16/2011EP2144901B1 Oligothiophene derivatives
03/16/2011EP2066643B1 Pyridazin-4-ylmethyl-sulfonamides used as fungicides and against arthropods
03/16/2011EP1940827B1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
03/16/2011EP1699761B1 Cb1 modulator compounds
03/16/2011EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists
03/16/2011CN101215300B Rhenium(I) tricarbonyl polypyridyl complex and its preparation method and use
03/15/2011US7906644 2,4-pyrimidinediamine compounds and their uses
03/15/2011US7906537 Substituted p-diaminobenzene derivatives
03/15/2011US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis
03/15/2011US7906513 Prevent reproduction; breaking life cycle;viricides
03/15/2011US7906512 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases
03/15/2011US7906503 Substituted 3-alkyl and 3-alkenyl azetidine derivatives
03/15/2011US7906235 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
03/15/2011CA2630665C Heterocyclic compound having inhibitory activity on 11-.beta.-hydroxysteroid dehydrogenase type i
03/15/2011CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 523